SCHEMBL20045514

SCHEMBL20045514

CCCC(O)(c1ccccc1)C1CCCCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 7/20 0.71
CHRM1 P11229 5/20 0.71
CYP2D6 P10635 4/20 0.71
KCNH2 Q12809 4/20 0.71
CHRM3 P20309 3/20 0.64
CHRM4 P08173 2/20 0.64
CHRM5 P08912 2/20 0.64
TSHR P16473 2/20 0.64
GRIN2D O15399 1/20 0.64
GRIN3B O60391 1/20 0.64
HRH1 P35367 1/20 0.64
GRIN1 Q05586 1/20 0.64
GRIN2A Q12879 1/20 0.64
GRIN2B Q13224 1/20 0.64
GRIN2C Q14957 1/20 0.64
GRIN3A Q8TCU5 1/20 0.64
CYP3A4 P08684 1/20 0.64
NFKB1 P19838 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
HTR1A P08908 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9910958 0.90 CHRM2 (0.68) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL2933098 0.86 CHRM2 (0.66) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL12441787 0.86 CHRM2 (0.66) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL10516359 0.83 CHRM2 (0.64) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL10392382 0.83 CHRM2 (0.64) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL7442966 0.83 CHRM2 (0.63) CHRM2CHRM1CYP2D6KCNH2CHRM3
Tridihexethyl SCHEMBL2296006 0.83 CHRM2 (1.00) CHRM2CHRM1CYP2D6KCNH2CHRM3
Tridihexethyl SCHEMBL94230 0.83 CHRM2 (1.00) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL9782807 0.83 CHRM2 (0.62) CHRM2CHRM1CYP2D6KCNH2CHRM3
Tridihexethyl SCHEMBL100471 0.82 CHRM2 (0.97) CHRM2CHRM1CYP2D6KCNH2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10414771-B2 Compounds useful for inhibiting metastasis from cancer and methods using same DREXEL UNIVERSITY (US) 2019-09-17 US disclosed
US-20180099972-A1 Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same UNIV DREXEL (US) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180099972-A1 Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same CX3CR1, CCL2, CCR5 CHRM2 273/4885CHRM1 480/4885CYP2D6 1623/4885
US-10414771-B2 Compounds useful for inhibiting metastasis from cancer and methods using same CX3CR1, CCL2, CCR5 CHRM2 273/4885CHRM1 480/4885CYP2D6 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.